https://www.businesswire.com/news/home/20230406005353/en/Avacta-Opens-First-Two-US-Clinical-Investigator-Sites-for-AVA6000-Phase-1-Clinical-Study
Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces the opening on 5 Apr...